The Patent Finder

Aerase, Inc.

Also on record
Records under this name other than the patents Aerase, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Aerase, Inc.

PatentTitleStatus Expires Confidence
US 10,729,752Compositions and methods for treating cancer with arginine depletion and immuno oncology agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,717,562Method and Composition for Treating Arginase 1 Deficiency
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,331,335Methods for Production of Human Recombinant Arginase 1 and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,144,848Arginine Depletion Therapy For Treatment of GAMT Deficiency
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,440,184Compositions of engineered human arginases and methods for treating cancer
Surrendered on reissue
Surrendered on reissue Jun 6, 2017 · From the USPTO record
Surrendered on reissueSurrendered on reissue Jun 6, 2017From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited